Virax Biolabs Group Limited filed its 20-F on Jun 14, 2023 for the period ending Mar 31, 2023. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 USD | +16.37% | +15.87% | -50.00% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-50.00% | 1.72M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.28% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- VRAX Stock
- News Virax Biolabs Group Limited
- Virax Biolabs Group Limited Auditor Raises 'Going Concern' Doubt